Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

What condition was this medication prescribed to treat?

What dosage were you prescribed daily?

Have any of the following side effects occurred? (Please check all that apply.)

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Scientist Cleared to Publish Vioxx Findings

Jan 3, 2005 | Dow Jones

The U.S. Food and Drug Administration will let Dr. David Graham, an FDA official who has criticized his employer, publish a study that links Merck & Co.'s (MRK) Vioxx pain treatment with heart attacks, the official's attorney said.

The FDA told Graham on Monday that he had permission to publish his research, which found that 88,000 to 139,000 people have had heart attacks that may be linked to Vioxx, with 30% to 40% of them fatal, his attorney, told Dow Jones Newswires.

The report has been submitted to British medical journal Lancet. The Financial Times reported earlier that the Lancet will probably publish Graham's research.

Graham has sharply criticized his employer, telling a congressional hearing in November that the FDA discounts recommendations from its own safety researchers.

Graham didn't immediately return a phone call for comment. An FDA spokeswoman couldn't immediately be reached. The Lancet's U.K. offices are closed for the holidays.

Merck is "not going to comment on an article that's not published," company spokeswoman Anita Larsen said.

Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo